A Study to Assess the Efficacy and Safety of Nusinersen (ISIS 396443) in Participants With Later-onset Spinal Muscular Atrophy (SMA)

NCT02292537 · clinicaltrials.gov ↗
PHASE3
Phase
COMPLETED
Status
126
Enrollment
INDUSTRY
Sponsor class

Conditions

Interventions

Sponsor

Biogen